History of Micrornas: From Gene Controlling Development of Nematodes to a Promising Tool for Molecular Therapy
By: Brany Dusan
References
- Gebert LF, MacRae IJ. Regulation of MicroRNA Function in Animals. Ann Intern Med 2019; 124 (11): 21–37.
- Kozomara A, Griffiths-Jones S. MiRBase: Annotating High Confidence MicroRNAs Using Deep Sequencing Data. Nucleic Acids Res 2014; 42 (D1): D68.
- Shang R, Lee S, Senavirathne G, Lai EC. MicroRNAs in Action: Biogenesis, Function and Regulation. Nat Rev Genet 2023; 24 (12): 816–833.
- O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol 2018; 9: 402.
- Friedman RC, Farh KK, Burge CB, Bartel DP. Most Mammalian MRNAs Are Conserved Targets of MicroRNAs. Genome Res 2009; 19 (1): 92–105.
- Tanzer A, Stadler PF. Molecular Evolution of a MicroRNA Cluster. J Mol Biol 2004; 339 (2): 327–335.
- Bartel DP. MicroRNAs: Target Recognition and Regulatory Functions. Cell 2009; 136 (2): 215–233.
- Nicholson AW. Ribonuclease III Mechanisms of Double-Stranded RNA Cleavage. Wiley Interdiscip Rev RNA 2014; 5 (1): 31–48.
- Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of Primary MicroRNAs by the Microprocessor Complex. Nature 2004; 432 (7014): 231–235.
- Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. The Drosha-DGCR8 Complex in Primary MicroRNA Processing. Genes Dev 2004; 18 (24): 3016–3027.
- Kim B, Jeong K, Kim VN. Genome-Wide Mapping of DROSHA Cleavage Sites on Primary MicroRNAs and Noncanonical Substrates. Mol Cell 2017; 66 (2): 258–269.e5.
- Stavast CJ, Erkeland SJ. The Non-Canonical Aspects of MicroRNAs: Many Roads to Gene Regulation. Cells 2019; 8 (11): 1465.
- Broughton JP, Lovci MT, Huang JL, Yeo GW, Pasquinelli AE. Pairing beyond the Seed Supports MicroRNA Targeting Specificity. Mol Cell 2016; 64 (2): 320–333.
- Bukhari SIA, Truesdell SS, Lee S, Kollu S, Classon A, Boukhali M, Jain E, Mortensen RD, Yanagiya A, Sadreyev RI, et al. A Specialized Mechanism of Translation Mediated by FXR1a-Associated MicroRNP in Cellular Quiescence. Mol Cell 2016; 61 (5): 760–773.
- Truesdell SS, Mortensen RD, Seo M, Schroeder JC, Lee JH, Letonqueze O, Vasudevan SV. MicroRNA-Mediated MRNA Translation Activation in Quiescent Cells and Oocytes Involves Recruitment of a Nuclear MicroRNP. Sci Rep 2012; 2 (1): 1–12.
- Chalfie M, Horvitz HR, Sulston JE. Mutations That Lead to Reiterations in the Cell Lineages of C. Elegans. Cell 1981; 24 (1): 59–69.
- Markaki M, Tavernarakis N. Caenorhabditis Elegans as a Model System for Human Diseases. Curr Opin Biotechnol 2020; 63: 118–125.
- Lee RC, Feinbaum RL, Ambros V. The C. Elegans Heterochronic Gene Lin-4 Encodes Small RNAs with Antisense Complementarity to Lin-14. Cell 1993; 75 (5): 843–854.
- Wightman B, Ha I, Ruvkun G. Posttranscriptional Regulation of the Heterochronic Gene Lin-14 by Lin-4 Mediates Temporal Pattern Formation in C. Elegans. Cell 1993; 75 (5): 855–862.
- Reinhart BJ, Slack FJ, Basson M, Pasquienell AE, Bettnger JC, Rougvle AE, Horvitz HR, Ruvkun G. The 21-Nucleotide Let-7 RNA Regulates Developmental Timing in Caenorhabditis Elegans. Nature 2000; 403 (6772): 901–906.
- Slack FJ, Basson M, Liu Z, Ambros V, Horvitz HR, Ruvkun G. The Lin-41 RBCC Gene Acts in the C. Elegans Heterochronic Pathway between the Let-7 Regulatory RNA and the LIN-29 Transcription Factor. Mol Cell 2000; 5 (4): 659–669.
- Wang Y, Tang X, Lu J. Convergent and Divergent Evolution of MicroRNA-Mediated Regulation in Metazoans. Biol Rev 2024; 99 (2): 525–545.
- Fromm B, Høye E, Domanska D, Zhong X, Aparicio-Puerta E, Ovchinnikov V, Umu SU, Chabot PJ, Kang W, Aslanzadeh M, et al. MirGeneDB 2.1: Toward a Complete Sampling of All Major Animal Phyla. Nucleic Acids Res 2022; 50 (D1): D204–D210.
- Dexheimer PJ, Cochella L. MicroRNAs: From Mechanism to Organism. Front Cell Dev Biol 2020; 8.
- Moran Y, Agron M, Praher D, Technau U. The Evolutionary Origin of Plant and Animal MicroRNAs. Nature Ecol Evol 2017; 1 (3): 1–8.
- Edelbroek B, Kjellin J, Biryukova I, Liao Z, Lundberg T, Noegel AA, Eichinger L, Friedländer MR, Söderbom F. Evolution of MicroRNAs in Amoebozoa and Implications for the Origin of Multicellularity. Nucleic Acids Res 2024; 52 (6): 3121–3136.
- Sirotkin AV, Ovcharenko D, Grossmann R, Lauková M, Mlynček M. Identification of MicroRNAs Controlling Human Ovarian Cell Steroidogenesis via a Genome-Scale Screen. J Cell Physiol 2009; 219 (2): 415–420.
- Sirotkin AV, Lauková M, Ovcharenko D, Brenaut P, Mlynček M. Identification of MicroRNAs Controlling Human Ovarian Cell Proliferation and Apoptosis. J Cell Physiol 2010; 223 (1): 49–56.
- Jurkovicova D, Lukackova R, Magyerkova M, Kulcsar L, Krivjanska M, Krivjansky V, Chovanec M. MicroRNA Expression Profiling as Supportive Diagnostic and Therapy Prediction Tool in Chronic Myeloid Leukemia. Neoplasma 2015; 62 (6): 949–957.
- Jurkovicova D, Magyerkova M, Sestakova Z, Copakova L, Bella V, Konecny M, Krivjanska M, Kulcsar L, Chovanec M. Evaluation of Expression Profiles of MicroRNAs and Two Target Genes, FOXO3a and RUNX2, Effectively Supports Diagnostics and Therapy Predictions in Breast Cancer. Neoplasma 2016; 63 (6): 941–951.
- Sirotkin AV, Alexa R, Kišová G, Harrath AH, Alwasel S, Ovcharenko D, Mlynček M. MicroRNAs Control Transcription Factor NF-KB (P65) Expression in Human Ovarian Cells. Funct Integr Genomics 2015; 15 (3): 271–275.
- Jurkovicova D, Magyerkova M, Kulcsar L, Krivjanska M, Krivjansky V, Gibadulinova A, Oveckova I, Chovanec M. MiR-155 as a Diagnostic and Prognostic Marker in Hematological and Solid Malignancies. Neoplasma 2014; 61 (3): 241–251.
- Gurianova V, Stroy D, Ciccocioppo R, Gasparova I, Petrovic D, Soucek M, Dosenko V, Kruzliak P. Stress Response Factors as Hub-Regulators of MicroRNA Biogenesis: Implication to the Diseased Heart. Cell Biochem Funct 2015; 33 (8): 509–518.
- Gardlik R, Celec P, Bernadic M. Targeting Angiogenesis for Cancer (Gene) Therapy. Bratisl Lek Listy 2011; 112 (8): 428–434. Tanzer A, Stadler PF. Molecular Evolution of a MicroRNA Cluster. J Mol Biol 2004; 339 (2): 327–335.
- Hatok J, Kmet’ová Sivoňová M, Babušíková E, Kliková K, Richterová R, Račay P. Využitie kvantitatívnej PCR techniky na profilovanie miRNA nádorových chorôb mozgu. Molekulová biológia vybraných nádorových ochorení a nové trendy pri ich diagnostike a liečbe. 2011; 5–9.
- Lasabová Z, Vazan M, Zibolenova J, Svecova I. Overexpression of MiR-21 and MiR-122 in Preeclamptic Placentas. Neuro Endocrinol Lett 2015; 36 (7): 695–699.
- Sarlinova M, Halasa M, Mistuna D, Musak L, Iliev R, Slaby O, Mazuchova J, Valentova V, Plank L, Halasova E. MiR-21, MiR-221 and MiR-150 Are Deregulated in Peripheral Blood of Patients with Colorectal Cancer. Anticancer Res 2016; 36 (10): 5449–5454.
- Holubekova V, Mendelova A, Jasek K, Mersakova S, Zubor P, Lasabova Z. Epigenetic Regulation by DNA Methylation and MiRNA Molecules in Cancer. Future Oncology 2017; 13 (25): 2217–2222.
- Holubekova V, Kolkova Z, Grendar M, Brany D, Dvorska D, Stastny I, Jagelkova M, Zelinova K, Samec M, Liskova A, et al. Pathway Analysis of Selected Circulating MiRNAs in Plasma of Breast Cancer Patients: A Preliminary Study. Int J Mol Sci 2020; 21 (19): 7288.
- Kolkova Z, Holubekova V, Grendar M, Nachajova M, Zubor P, Pribulova T, Loderer D, Zigo I, Biringer K, Hornakova A. Association of Circulating MiRNA Expression with Preeclampsia, Its Onset, and Severity. Diagnostics 2021; 11 (3): 476.
- Kudelova E, Holubekova V, Grendar M, Kolkova Z, Samec M, Vanova B, Mikolajcik P, Smolar M, Kudela E, Laca L, et al. Circulating MiRNA Expression over the Course of Colorectal Cancer Treatment. Oncol Lett 2022; 23 (1).
- Krivosova M, Adamcakova J, Kaadt E, Mumm BH, Dvorska D, Brany D, Dankova Z, Dohal M, Samec M, Ferencova N, et al. The VEGF Protein Levels, MiR-101-3p, and MiR-122-5p Are Dysregulated in Plasma from Adolescents with Major Depression. J Affect Disord 2023; 334: 60–68.
- Benko J, Sarlinova M, Mikusova V, Bolek T, Pec MJ, Halasova E, Galajda P, Samos M, Mokan M. MiR-126 and MiR-146a as Markers of Type 2 Diabetes Mellitus: A Pilot Study. Bratisl Lek Listy 2023; 124 (7): 527–533.
- Evin D, Evinová A, Baranovičová E, Šarlinová M, Jurečeková J, Kaplán P, Poláček H, Halašová E, Dušenka R, Briš L, et al. Integrative Metabolomic Analysis of Serum and Selected Serum Exosomal MicroRNA in Metastatic Castration-Resistant Prostate Cancer. Int J Mol Sci 2024; 25 (5): 2630.
- Samec M, Liskova A, Kubatka P, Uramova S, Zubor P, Samuel SM, Zulli A, Pec M, Bielik T, Biringer K, et al. The Role of Dietary Phytochemicals in the Carcinogenesis via the Modulation of MiRNA Expression. J Cancer Res Clin Oncol 2019; 145 (7): 1665–1679.
- Zubor P, Kubatka P, Kajo K, Dankova Z, Polacek H, Bielik T, Kudela E, Samec M, Liskova A, Vlcakova D, et al. Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy MiRNA Profiles to Breast Cancer Disease Management. Int J Mol Sci 2019; 20 (12): 2878.
- Zubor P, Kubatka P, Dankova Z, Gondova A, Kajo K, Hatok J, Samec M, Jagelkova M, Krivus S, Holubekova V, et al. MiRNA in a Multiomic Context for Diagnosis, Treatment Monitoring and Personalized Management of Metastatic Breast Cancer. Future Oncol 2018; 14 (18): 1847–1867.
- Varghese E, Liskova A, Kubatka P, Samuel SM, Büsselberg D. Anti-Angiogenic Effects of Phytochemicals on MiRNA Regulating Breast Cancer Progression. Biomolecules 2020; 10 (2).
- Hornakova A, Kolkova Z, Holubekova V, Loderer D, Lasabova Z, Biringer K, Halasova E. Diagnostic Potential of MicroRNAs as Biomarkers in the Detection of Preeclampsia. 2020; 24 (6): 321–327.
- Saiyed AN, Vasavada AR, Johar SRK. Recent Trends in MiRNA Therapeutics and the Application of Plant MiRNA for Prevention and Treatment of Human Diseases. Future J Pharm Sci. 2022; 8 (1): 1–20.
- Diener C, Keller A, Meese E. Emerging Concepts of MiRNA Therapeutics: From Cells to Clinic. Trends Genet. 2022; 38 (6): 613–626.
- Nam DY, Rhee JK. Identifying MicroRNAs Associated with Tumor Immunotherapy Response Using an Interpretable Machine Learning Model. Sci Rep. 2024; 14 (1): 1–15.
- Cortez MA, Anfossi S, Ramapriyan R, Menon H, Atalar SC, Aliru M, Welsh J, Calin GA. Role of MiRNAs in Immune Responses and Immunotherapy in Cancer. Genes Chromosomes Cancer. 2019; 58 (4): 244
- Yang Y, Guo L, Chen L, Gong B, Jia D, Sun Q. Nuclear Transport Proteins: Structure, Function and Disease Relevance. Signal Transduct Target Ther. 2023; 8 (1): 1–29.
- Seyhan AA. Trials and Tribulations of MicroRNA Therapeutics. Int J Mol Sci. 2024; 25 (3): 1469.
- Dhuri K, Bechtold C, Quijano E, Pham H, Gupta A, Vikram A, Bahal R. Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development. J Clin Med. 2020; 9 (6): 2004.
- Jiao LR, Frampton AE, Jacob J, Pellegrino L, Krell J, Giamas G, Tsim N, Vlavianos P, Cohen P, Ahmad R, et al. MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors. PLoS One. 2012; 7 (2): e32068.
- Iacomino G. MiRNAs: The Road from Bench to Bedside. Genes (Basel). 2023; 14 (2): 314.
Language: English
Page range: 153 - 162
Submitted on: Nov 9, 2024
Accepted on: Nov 10, 2024
Published on: Dec 20, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
Related subjects:
© 2024 Brany Dusan, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.